Latest news for Gruma SAB (OTC:GMKKY) Stock

Gruma SAB de CV is an international food production company, originally from Mexico. The product portfolio is large: corn and flour tortillas, wheat flour, naan, pita bread, flatbreads, wraps, chapatti, and pizza bases, along with other food products, such as snacks, pasta, rice, condiments, and palm hearts. The company has operations in America, Europe, Asia, and Oceania, and is present in over 100 countries across the globe. Its well-known brands are Maseca, Robin Hood, Mission, Guerrero, Tortiricas and Tosty.

GRUMA SAB DE CV UNSP/ADR by Gruma S.A.B. de CV

Gruma SAB de CV

Pennsylvania Governor Josh Shapiro (D) said that both his administration and lawmakers would &#8220;come back and continue to fight&#8221; for legalization, referring to the exclusion of cannabis reform in the <a href="https://www.benzinga.com/markets/cannabis/24/07/39776331/these-two-cannabis-stocks-face-setback-following-pennsylvania-budget-approval-what-you-need-to-k">recently signed budget legislation</a>.
During a <a href="https://www.facebook.com/watch/?v=1479628103436767">press conference</a>, Shapiro reflected on the compromises made in the budget, emphasizing his continued belief in the reform&#8217;s potential benefits. 
Shapiro&#8217;s initial <a href="https://www.benzinga.com/markets/cannabis/24/02/36982547/pa-gov-wants-cannabis-legalized-its-time-to-catch-up-with-other-states-and-earn-250m-in-revenue-">budget proposal</a> in February included cannabis legalization, highlighting the revenue potential as neighboring states move ahead with the reform. He pointed out the financial opportunities, stating, &#8220;We're losing out on an industry that, once fully implemented, would bring in more than $250 million in annual revenue.&#8221;
<h4 class="wp-block-heading">Lawmaker On Legalization Efforts</h4>
However, the path to legalization faces internal disagreements among Pennsylvania Democrats regarding the regulatory framework. Rep. Dan Frankel, a staunch advocate for marijuana legalization, acknowledged the lack of consensus on whether to adopt a traditional private model or a <a href="https://www.benzinga.com/markets/cannabis/24/04/38448103/state-run-vs-private-pennsylvania-debates-transition-of-liquor-store-model-to-cannabis-distribut">state-controlled system</a> comparable to the alcohol industry.
Frankel noted that cannabis reform was not a focal point in the recent budget negotiations, expressing doubts about advancing legalization this year due to limited session days. Nevertheless, he remained optimistic about future discussions and Republican engagement on the matter.
Senate president pro tempore Kim Ward criticized the governor&#8217;s involvement. &#8220;It's a lot of show, but not a lot of ‘go,' as far as I'm concerned.&#8221; 
<h4 class="wp-block-heading">Industry And Advocacy Group Weigh In</h4>
Meredith Buettner Schneider, executive director of the Pennsylvania Cannabis Coalition, expressed hope for legislative progress this fall. She emphasized the importance of the governor&#8217;s involvement. &#8220;[Shapiro] coming to the table over the next couple months would be really critical to getting something done.&#8221;
Amid legislative efforts, the Pennsylvania legislature inadvertently omitted medical marijuana dispensaries from a section providing tax relief for the cannabis industry in the budget bill. This error underscores the complex and often contentious nature of cannabis policy reform.
<h4 class="wp-block-heading">Projections And Future Outlook</h4>
A recent <a href="https://s43720.pcdn.co/wp-content/uploads/2024/06/FTI-PA-Adult-Use-Market-Economic-Impacts-06.17.2461.pdf">report</a> commissioned by activists projected that Pennsylvania could see up to $2.8 billion in adult-use marijuana sales in the first year of legalization, generating significant tax revenue and job creation. Sens. Sharif Street and Dan Laughlin stressed the importance of bipartisan cooperation to pass a legalization bill, advocating for the <a href="https://www.benzinga.com/markets/cannabis/24/01/36620822/feds-finally-release-documents-confirming-recommendation-to-reschedule-cannabis-based-on-accepte">federal government&#8217;s proposed cannabis rescheduling rule</a> to be implemented swiftly.
In light of regional legalization dynamics and increasing public support, Pennsylvania&#8217;s journey toward marijuana reform continues to unfold. Lawmakers and advocates say they&#8217;re determined to achieve a consensus that balances regulatory considerations, economic opportunities and <a href="https://www.benzinga.com/markets/cannabis/24/07/39708899/no-cannabis-legalization-in-pennsylvania-without-our-support-says-black-caucus-urging-for-restor">social equity</a>.
Cover image created with AI

Cannabis

Government

News

Psychedelics

Politics

Gov Josh Shapiro Says He'll Push For Marijuana Legalization In Pennsylvania Despite Setbacks

Pentagon Says First F-35 Of New Deliveries Accepted On Friday

Despite recent layoffs in its Reality Labs division, Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is moving forward with ambitious plans for its virtual reality (VR) and <a href="https://www.benzinga.com/topic/arvr">augmented reality (AR) hardware. </a>
<a href="https://www.theinformation.com/articles/reality-comes-to-metas-reality-labs">According</a> to The Information, the company aims to release the Quest 4 in 2026, followed by a higher-end headset in 2027.
See Also: <a href="https://www.benzinga.com/general/gaming/24/04/38342816/meta-quest-2-price-permanently-cut-in-half-concerns-linger-about-long-term-support">Meta Quest 2 Price Permanently Cut In Half, Concerns Linger About Long-Term Support</a>
<h3 class="wp-block-heading">Quest 4 And High-End Headset Timelines</h3>
For the first time, specific timelines for these upcoming devices have surfaced. The Quest 4 is expected to come in two versions, internally referred to as &#8220;Pismo Low&#8221; and &#8220;Pismo High.&#8221; This bifurcation suggests Meta&#8217;s strategy to cater to both budget-conscious consumers and those seeking a premium VR experience.
The 2027 release, codenamed &#8220;La Jolla,&#8221; aims to position itself as a direct competitor to the <a href="https://www.benzinga.com/news/24/07/39747111/apples-vision-pro-struggles-to-find-its-killer-app-to-justify-3-500-price-tag-just-not-quite-hit-the">Apple Vision Pro.</a>
<h3 class="wp-block-heading">AR Glasses And Design Challenges</h3>
Meta&#8217;s ambitions aren&#8217;t limited to VR headsets. The company is also planning to launch a pair of AR glasses featuring a genuine display. 
However, The Information&#8217;s report indicates that these glasses might face significant design hurdles. Unlike the lightweight Ray-Ban Meta smart glasses, the new AR glasses are expected to weigh around 70 grams and have a &#8220;bulky design&#8221; due to the integrated display.
This design challenge is a familiar one in the AR industry. Achieving a balance between wearability, battery life, and display performance remains a tough nut to crack. The report suggests that due to their bulkiness, these glasses may not carry the Ray-Ban branding, as Ray-Ban&#8217;s parent company, EssilorLuxottica, reportedly disapproves of the design.
Many companies have faced similar challenges in miniaturizing displays to create comfortable, stylish, and functional AR glasses. This difficulty has often been a significant barrier to widespread consumer adoption.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/gaming/23/06/32935115/xbox-stays-clear-of-vr-is-the-market-too-small-to-gamble-on">Xbox Stays Clear Of VR: Is the Market Too Small To Gamble On?</a></li>
</ul>
Photo Shutterstock

Gaming

Tech

General

Meta Moves Ahead With Quest 4 VR Headset Despite Layoffs, Sets Release Date: Report

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Adverum Biotechnologies</h3>
<ul>
<li>The Trade: Adverum Biotechnologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) 10% owner Braden Michael Leonard <a href="https://www.benzinga.com/quote/ADVM/analyst-ratings">acquired a total of 216,264 shares</a> at an average price of $8.26. To acquire these shares, it cost around $1.79 million.</li>
<li>What's Happening: On July 17, Adverum Biotechnologies released data from its ongoing LUNA Phase 2 trial for Ixo-vec in patients with wet age-related macular degeneration (AMD).</li>
<li>What Adverum Biotechnologies Does: Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company.</li>
</ul>
<h3 class="wp-block-heading">Appian</h3>
<ul>
<li>The Trade: Appian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPN#NASDAQ">APPN</a>) 10% owner Colin T. Moran acquired a total of 300,000 shares at &lt;/em&gt;&lt;/a&gt; an average price of $35.40. To acquire these shares, it cost around $10.6 million.</li>
<li>What's Happening: Appian will release financial results for the second quarter, before the opening bell on Thursday, Aug. 1.</li>
<li>What Appian Does: Appian is a low-code enterprise platform-as-a-service company focusing on business process management.</li>
</ul>
<h3 class="wp-block-heading">American Strategic Investment</h3>
<ul>
<li>The Trade: American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) 10% owner New York City Advisors, LLC <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 125,864 shares</a> at an average price of $10.98. To acquire these shares, it cost around $1.38 million.</li>
<li>What's Happening: On May 10, the company posted downbeat quarterly sales.</li>
<li>What American Strategic Investment Does: American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39859847/netflix-to-rally-more-than-10-here-are-10-top-analyst-forecasts-for-friday">Netflix To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Friday</a></li>
</ul>

Long Ideas

Insider Trades

Intraday Update

Markets

Trading Ideas

ADVM

APPN

More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying

Northern Irish golf sensation Rory McIlroy has weathered a few missed putts lately. According to the Daily Mail, after a brief foray into divorce proceedings, McIlroy and his wife of seven years, Erica Stoll, have opted for reconciliation. This decision inadvertently exposed the golfer&#8217;s unexpected windfall in Florida's real estate market.
Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>Will the surge continue or decline on real estate prices?<a href="https://www.benzinga.com/money/realbricks"> People are finding out about risk-free real estate investing that lets you cash out whenever you want.</a></li>
</ul>
The couple&#8217;s Jupiter, Florida mansion, purchased for $11 million in 2012, has doubled in value to an estimated $22 million. The appreciation came during a tumultuous period for the McIlroys, culminating in a divorce filing on the eve of the PGA Championship in May, only to be dramatically withdrawn weeks later.
"There have been rumors about my personal life recently, which is unfortunate," McIlroy told The Guardian last month. "Over the past weeks, Erica and I have realized that our best future was as a family together."
The personal drama played out against McIlroy&#8217;s professional challenges, including a heartbreaking near-miss at the U.S. Open in Pinehurst. The golfer held a two-shot lead with four holes to play before stumbling to a second-place finish behind Bryson DeChambeau.
The 13,000-square-foot <a href="https://www.benzinga.com/general/24/06/39332812/they-broke-up-in-1989-but-now-his-ex-girlfriend-is-inheriting-his-1-million-retirement-account-after">residence — </a>on 2.4 acres of land — boasts nine bedrooms and ten bathrooms. Beyond its sheer size, the mansion has a luxury infinity pool, a games room, a tennis court, a home theater, and a recording studio. The property includes a state-of-the-art gym and a six-car garage. Its value has surged alongside the broader luxury real estate market in South Florida, a trend accelerated by the pandemic&#8217;s reshuffling of living preferences.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
McIlroy&#8217;s <a href="https://www.benzinga.com/personal-finance/24/07/39694555/28-year-old-making-500-000-a-year-explains-to-dave-ramsey-his-fianc-es-rich-parents-want-him-to-">prenuptial agreement,</a> signed in 2017, reportedly allows him to retain ownership of the property and his golf fortune. The golfer&#8217;s attorney, Thomas Sasser, previously represented Tiger Woods in his 2010 divorce. Given Florida&#8217;s equitable distribution laws and the prenuptial agreement, legal experts suggested that McIlroy&#8217;s estimated $87 million in career earnings might not be seriously impacted if they were to get divorced. However, this isn&#8217;t the first time McIlroy&#8217;s personal life has crossed with his professional career. His past relationships, including those with childhood sweetheart Holly Sweeney and tennis star Caroline Wozniacki, ended abruptly, sometimes coinciding with major tournaments.
As McIlroy returns to competition at the Scottish Open, the golfer&#8217;s resilience, evident in his return to the links after the U.S. Open disappointment, seems to extend beyond the fairways. "I&#8217;ve shown my resilience over and over again in the last 17 years," McIlroy said in a recent statement, "and I will again." 
Read Next:
<ul>
<li>Gen Z and Millennial millionaires couldn't care less for stocks and bonds —<a href="https://www.benzinga.com/money/gen-z-and-millennial-millionaires-investments-adv"> Here's what they're buying instead.</a></li>
<li>General Motors and other leaders revealed to be<a href="https://www.benzinga.com/money/energyx"> investing in this revolutionary lithium start-up — allowing easy entry by launching at just $9.50 per share.</a></li>
</ul>

Real Estate

Rory McIlroy's Prenup Terms Allows Him To Keep His $22 Million Mansion Even Though Home Value Doubled Since 2017

<a href="https://www.businessinsider.com/tesla-production-lines-impacted-microsoft-crowdstrike-it-outage-2024-7" title="https://www.businessinsider.com/tesla-production-lines-impacted-microsoft-crowdstrike-it-outage-2024-7">https://www.businessinsider.com/tesla-production-lines-impacted-microsoft-crowdstrike-it-outage-2024-7</a>

TSLA

'Tesla halted some of its production lines due to the Microsoft-CrowdStrike outage' - Insider

Truist Securities analyst Michael Ciarmoli maintains Hexcel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HXL#NYSE">HXL</a>) with a Buy and lowers the price target from $81 to $78.

Price Target

Analyst Ratings

Truist Securities Maintains Buy on Hexcel, Lowers Price Target to $78

ARM Holdings Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) shares are trading higher after Morgan Stanley analyst Lee Simpson upgraded the stock from <a target="_blank" href="https://www.benzinga.com/quote/ARM/analyst-ratings" rel="noreferrer noopener">Equal-Weight to Overweight</a> and raised its price target from $107 to $190.
The upgrade comes as the broader semiconductor sector has seen a selloff this week following Donald Trump&#8217;s <a target="_blank" href="https://www.benzinga.com/government/24/07/39857131/ai-chip-stocks-nvidia-amd-taiwan-semi-saw-a-selloff-this-week-whats-going-on" rel="noreferrer noopener">verbal attack against</a> contract chipmaker Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) and the U.S.&#8217;s plans to intensify advanced semiconductor sanctions against China.
AI chip stocks led by Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) lost 9% and 18% this week.
<a target="_blank" href="https://www.benzinga.com/news/24/06/39135597/why-is-arm-holdings-stock-trading-higher-on-monday" rel="noreferrer noopener">At the Computex forum</a> in Taipei, Arm CEO Rene Haas said he expects 100 billion Arm devices worldwide to be AI-ready by the end of 2025.
Arm Holdings plans to showcase its AI chip in 2025 and launch it commercially by fall 2025. Parent company Softbank Group Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) aims to invest significantly in data centers using its AI chips and renewable energy.
AMD CFO Jean Hu recently suggested a potential entry into next-generation AI PCs.
Analysts remain optimistic about Arm Holdings, citing strong licensing interest and royalty potential as essential growth factors. They also highlight Arm&#8217;s opportunities in the AI and data center sectors.
Arm Holdings stock rose by 158% over the past 12 months as AI <a target="_blank" href="https://www.benzinga.com/news/24/06/39387100/whats-going-on-with-chipmaker-arm-holdings-stock" rel="noreferrer noopener">integrated into smartphones</a>. The ARM (Acorn RISC Machine) architecture powers 99% of the world&#8217;s smartphone CPU cores. Apple, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is one of Arm&#8217;s major customers.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/19120052/newplot-1-9.png" alt="" class="wp-image-446149" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/19120052/newplot-1-9.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/19120052/newplot-1-9-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Arm&#8217;s clients choose the company over Intel Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) x86 technology primarily for its efficiency and widespread adoption. Arm&#8217;s architecture enables chips to consume less power compared to x86, making it ideal for mobile devices and other power-sensitive applications, CNBC <a target="_blank" href="https://www.cnbc.com/2023/11/09/how-arm-gained-chip-dominance-with-apple-nvidia-amazon-and-qualcomm.html" rel="noreferrer noopener">reported</a> in 2023.
Key clients like Apple, Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Qualcomm Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) leverage Arm&#8217;s technology to build custom silicon tailored to their specific needs.
ARM Holdings has a consensus price target of&nbsp;$112.17 based on the ratings of&nbsp;25 analysts.
ARM Price Action: Arm shares traded higher by 3.47% at $163.83 at the last check on Friday.
Photo via Wikimedia Commons

Upgrades

Movers

AAPL

AMZN

GOOG

GOOGL

INTC

MSFT

NVDA

QCOM

SFTBF

SFTBY

What's Going On With Arm Stock On Friday?

Northcoast Research analyst Ryan Connors downgrades Pentair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) from Buy to Neutral.

Downgrades

Northcoast Research Downgrades Pentair to Neutral

BTIG analyst Thomas Catherwood assumes Apollo Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARI#NYSE">ARI</a>) with a Neutral rating.

Initiation

BTIG Assumes Apollo Comml Real Est at Neutral

BTIG analyst Sarah Barcomb assumes Claros Mortgage Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMTG#NYSE">CMTG</a>) with a Neutral rating.

CMTG

BTIG Assumes Claros Mortgage Trust at Neutral

Morgan Stanley analyst Michael Phillips maintains Travelers Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) with a Equal-Weight and lowers the price target from $220 to $210.

Morgan Stanley Maintains Equal-Weight on Travelers Companies, Lowers Price Target to $210

BTIG analyst Timothy Hayes assumes Ready Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RC#NYSE">RC</a>) with a Neutral rating.

BTIG Assumes Ready Capital at Neutral

Goldman Sachs analyst Eric Sheridan maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Neutral and raises the price target from $650 to $659.

NFLX

Goldman Sachs Maintains Neutral on Netflix, Raises Price Target to $659

Goldman Sachs analyst Alex Scott maintains Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) with a Buy and raises the price target from $197 to $199.

Goldman Sachs Maintains Buy on Allstate, Raises Price Target to $199

Goldman Sachs analyst Chris Shibutani maintains Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) with a Neutral and lowers the price target from $160 to $155.

Goldman Sachs Maintains Neutral on Johnson & Johnson, Lowers Price Target to $155

Resources Connection (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rgp#NYSE">RGP</a>) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.44 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 180%. A quarter ago, it was expected that this consulting company would post a loss of $0.01 per share when it actually produced earnings of $0.17, delivering a surprise of 1,800%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Resources Connection, which belongs to the Zacks Staffing Firms industry, posted revenues of $148.2 million for the quarter ended May 2024, surpassing the Zacks Consensus Estimate by 5.61%. This compares to year-ago revenues of $184.45 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Resources Connection shares have lost about 22.6% since the beginning of the year versus the S&amp;P 500&#39;s gain of 17.2%.
What&#39;s Next for Resources Connection?
While Resources Connection has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Resources Connection: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.22 on $153.24 million in revenues for the coming quarter and $1.01 on $659.69 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Staffing Firms is currently in the top 33% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Insperity, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nsp#NYSE">NSP</a>), is yet to report results for the quarter ended June 2024.
This company is expected to post quarterly earnings of $0.73 per share in its upcoming report, which represents a year-over-year change of +14.1%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Insperity, Inc.&#39;s revenues are expected to be $1.62 billion, up 2.2% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2304865/resources-connection-rgp-beats-q4-earnings-and-revenue-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2304865">To read this article on Zacks.com click here.</a>

Earnings

Earnings Beats

Small Cap

Resources Connection Beats Q4 Earnings and Revenue Estimates

Wall Street Journal reporter Evan Gershkovich has been sentenced to 18 years in prison in <a href="https://www.benzinga.com/topic/evan-gershkovich">a Russian trial</a> denounced by his employer and <a href="https://www.benzinga.com/topic/joe-biden">President Joe Biden</a>.
What Happened: The Journal <a href="https://www.wsj.com/world/russia/evan-gershkovich-russia-trial-dbabd6e3?mod=evan_gershkovich_lead_pos1">reported</a> that Gershkovich, who was arrested in 2023, was sentenced by a Russian court to 18 years in prison following a secret trial. Russia accused the American-born journalist of espionage while providing no evidence. 
"This disgraceful, sham conviction comes after Evan has spent 478 days in prison, wrongfully detained, away from his family and friends, prevented from reporting, all for doing his job as a journalist,"&nbsp;Almar Latour, publisher of The Wall Street Journal, and Editor in Chief&nbsp;Emma Tucker&nbsp;said in a statement.&nbsp;"We will continue to do everything possible to press for Evan's release and to support his family."
Biden offered a similar rebuke of Russian authorities in a <a href="https://www.whitehouse.gov/briefing-room/statements-releases/2024/07/19/statement-by-president-joe-biden-on-the-sentencing-of-wrongfully-detained-american-evan-gershkovich/">statement</a> published Friday.
&#8220;As I have long said and as the UN also concluded, there is no question that Russia is wrongfully detaining Evan. Journalism is not a crime,&#8221; the president said. &#8220;We will continue to stand strong for press freedom in Russia and worldwide, and stand against all those who seek to attack the press or target journalists.&#8221;
Why it Matters: John J. Sullivan, former ambassador to Russia, <a href="https://www.wsj.com/articles/u-s-russia-rift-complicates-case-of-arrested-journal-reporter-585946be">told</a> the Journal that Gershgovich was likely detained as a preliminary move to set up a prisoner swap. 
A deal between the U.S. and Russia could bring Gershkovich home if the U.S. returns an imprisoned Russian. Russian President Vladimir Putin said that a <a href="https://www.benzinga.com/general/politics/24/06/39534917/american-reporter-accused-of-spying-goes-to-trial-in-russia-is-prisoner-swap-his-best-hope">deal could be made</a> in a February interview.
Tensions between Russia and the Western world have escalated since the <a href="https://www.benzinga.com/topic/russia-ukraine-war">country invaded Ukraine</a> in 2022.
The U.S. and Russia agreed to <a href="https://www.benzinga.com/markets/cannabis/24/05/38619573/brittney-griners-memoir-testament-to-personal-resilience-russian-oppression-hits-bookshelves-may">a prisoner swap</a> that year; the U.S. exchanged Russian arms dealer Viktor Bout for <a href="https://www.state.gov/russias-continued-wrongful-detention-of-brittney-griner/">wrongfully detained</a> WNBA player Brittney Griner.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/07/39737184/us-germany-sniff-out-russian-attempt-to-assassinate-german-ceo">US, Germany Sniff Out Russian Attempt To Assassinate German CEO</a></li>
</ul>
Photo by Michael Parulava on Unsplash

Global

Media

WSJ Reporter Evan Gershkovich Gets 18-Year Sentence In Russia: Employer Calls Trial A 'Sham'

Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) revealed 12 unusual trades.
Delving into the details, we found 66% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $220,662, and 8 were calls, valued at $807,070.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $90.0 to $150.0 for Novo Nordisk over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Novo Nordisk's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Novo Nordisk's significant trades, within a strike price range of $90.0 to $150.0, over the past month.
<h3>Novo Nordisk Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721408507_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$4.45</td>
<td>$4.3</td>
<td>$4.45</td>
<td>$135.00</td>
<td>$511.7K</td>
<td>759</td>
<td style="text-align: right;">541</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$6.8</td>
<td>$6.7</td>
<td>$6.7</td>
<td>$135.00</td>
<td>$97.7K</td>
<td>1.4K</td>
<td style="text-align: right;">17</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$3.4</td>
<td>$3.3</td>
<td>$3.4</td>
<td>$145.00</td>
<td>$86.0K</td>
<td>7.8K</td>
<td style="text-align: right;">6</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$14.2</td>
<td>$14.05</td>
<td>$14.11</td>
<td>$145.00</td>
<td>$56.4K</td>
<td>791</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$6.9</td>
<td>$6.85</td>
<td>$6.9</td>
<td>$130.00</td>
<td>$37.9K</td>
<td>1.4K</td>
<td style="text-align: right;">80</td>
</tr>
</tbody>
</table>

<h3>About Novo Nordisk</h3>
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Following our analysis of the options activities associated with Novo Nordisk, we pivot to a closer look at the company's own performance.
<h3>Current Position of Novo Nordisk</h3>
<ul>
<li>With a volume of 2,060,022, the price of NVO is up 2.15% at $132.78. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 19 days.</li>
</ul>
<h3>What Analysts Are Saying About Novo Nordisk</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $161.0.
<ul>
<li>An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $160. </li>
<li>An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $160. </li>
<li>Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on Novo Nordisk with a target price of $163. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Novo Nordisk, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Novo Nordisk Options Trading: A Deep Dive into Market Sentiment

Benzinga's options scanner just detected over 8 options trades for Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) summing a total amount of $309,250.
At the same time, our algo caught 3 for a total amount of 99,565.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $170.0 for Chevron over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Chevron's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Chevron's whale activity within a strike price range from $150.0 to $170.0 in the last 30 days. 
<h3>Chevron Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721408503_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/23/24</td>
<td>$1.07</td>
<td>$1.06</td>
<td>$1.07</td>
<td>$170.00</td>
<td>$64.2K</td>
<td>924</td>
<td style="text-align: right;">23</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$7.05</td>
<td>$6.95</td>
<td>$7.05</td>
<td>$165.00</td>
<td>$58.5K</td>
<td>2.0K</td>
<td style="text-align: right;">8</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.1</td>
<td>$6.0</td>
<td>$6.1</td>
<td>$170.00</td>
<td>$46.9K</td>
<td>4.5K</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/02/24</td>
<td>$2.6</td>
<td>$2.58</td>
<td>$2.6</td>
<td>$162.50</td>
<td>$39.0K</td>
<td>1.8K</td>
<td style="text-align: right;">135</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$4.3</td>
<td>$4.25</td>
<td>$4.25</td>
<td>$150.00</td>
<td>$36.1K</td>
<td>2.0K</td>
<td style="text-align: right;">39</td>
</tr>
</tbody>
</table>

<h3>About Chevron</h3>
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.1 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.8 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2023 stood at 11.1 billion barrels of oil equivalent, including 6.0 billion barrels of liquids and 30.4 trillion cubic feet of natural gas.
Following our analysis of the options activities associated with Chevron, we pivot to a closer look at the company's own performance.
<h3>Current Position of Chevron</h3>
<ul>
<li>Trading volume stands at 2,426,089, with CVX's price down by -0.81%, positioned at $160.66.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 14 days.</li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Chevron, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Gruma SAB

News

Latest news for Gruma SAB (OTC:GMKKY) Stock